Is There a Place for PD-1-PD-L Blockade in Acute Myeloid Leukemia?

Checkpoint inhibitors were a major breakthrough in the field of oncology. In September 2014, based on the KEYNOTE-001 study, the Food and Drug Administration (FDA) approved pembrolizumab, a programmed cell death protein 1 (PD-1) inhibitor, for advanced or unresectable melanoma. Up until now, seven P...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura Jimbu (Author), Oana Mesaros (Author), Cristian Popescu (Author), Alexandra Neaga (Author), Iulia Berceanu (Author), Delia Dima (Author), Mihaela Gaman (Author), Mihnea Zdrenghea (Author)
Format: Book
Published: MDPI AG, 2021-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available